Blocking receptor in key hormone fires up enzyme to kill pancreatic cancer cells (EurekAlert, 10 August 2011)

Egg’s movements predict embryo’s chance of survival, study suggests (Wellcome Trust News, 10 August 2011)

MHRA Drug Safety Update: Risk of bladder cancer with pioglitazone (NeLM News Service, 9 August 2011)

10 Aug 2011

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has published guidance on the use of pioglitazone. The guidance includes findings from the recent European Medicines Agency safety review of pioglitazone, which investigated reports of increased incidence of bladder cancer in patients taking the drug.

Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Most read